| dc.contributor.advisor | Senge, Mathias O. | |
| dc.contributor.advisor | Ehrhardt, Carsten | |
| dc.contributor.author | Paszko, Edyta | |
| dc.date.accessioned | 2017-02-08T14:03:21Z | |
| dc.date.available | 2017-02-08T14:03:21Z | |
| dc.date.issued | 2013 | |
| dc.identifier.citation | Edyta Paszko, 'Investigation of novel photosensitisers for photodynamic cancer therapy', [thesis], Trinity College (Dublin, Ireland). School of Chemistry, 2013, pp 170 | |
| dc.identifier.other | THESIS 10291 | |
| dc.description.abstract | Photodynamic therapy (PDT) has developed over last century and is now becoming a more widely used medical tool having gained regulatory approval for the treatment of various diseases such as cancer and macular degeneration. It is based on photochemical reactions between light and tumour tissue with exogenous photosensitising agents (PS), most often porphyrins. Photochemical reactions lead to the conversion of molecular oxygen (3O2) into singlet oxygen (1O2) which is a key cytotoxic agent that damages cells. | |
| dc.format | 1 volume | |
| dc.language.iso | en | |
| dc.publisher | Trinity College (Dublin, Ireland). School of Chemistry | |
| dc.relation.isversionof | http://stella.catalogue.tcd.ie/iii/encore/record/C__Rb15651894 | |
| dc.subject | Chemistry, Ph.D. | |
| dc.subject | Ph.D. Trinity College Dublin | |
| dc.title | Investigation of novel photosensitisers for photodynamic cancer therapy | |
| dc.type | thesis | |
| dc.type.supercollection | thesis_dissertations | |
| dc.type.supercollection | refereed_publications | |
| dc.type.qualificationlevel | Doctoral | |
| dc.type.qualificationname | Doctor of Philosophy (Ph.D.) | |
| dc.rights.ecaccessrights | openAccess | |
| dc.format.extentpagination | pp 170 | |
| dc.description.note | TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie | |
| dc.identifier.uri | http://hdl.handle.net/2262/79303 | |
